20VC: Brex Acquired for $5.15BN | a16z Companies are 2/3 AI Revenues | Anthropic Inference Costs Skyrocket | OpenEvidence Raises at $12BN Valuation | The IPO Market: EquipmentShare, Wealthfront and Ethos Insurance
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
00:00
Is OpenEvidence a generational company?
The trio debate whether OpenEvidence's market position and founder pedigree justify aggressive late-stage pricing.
Play episode from 43:31
Transcript
